Trials / Completed
CompletedNCT04276948
Effects of NAD3 Supplementation on Biomarkers of Aging
Effects of NAD3 Supplementation on Biomarkers of Anti-Aging in Healthy Men and Women
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- The Center for Applied Health Sciences, LLC · Industry
- Sex
- All
- Age
- 40 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This is a randomized, parallel-group, placebo-controlled, clinical trial in middle-aged and older male and female subjects from Ohio. Subjects will take an over-the-counter dietary supplement or a placebo for 12 weeks. Outcome measures will include body weight, systolic and diastolic blood pressure, standard blood chemistries (e.g. chemistry panel, lipid panel, CBC with differential), changes in mood, vitality, energy, fatigue, productivity, digestive wellness (via anchored Visual Analogue Scales).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | NAD3 | NAD3 is an over-the-counter dietary supplement available online to consumers. |
Timeline
- Start date
- 2020-06-08
- Primary completion
- 2021-01-29
- Completion
- 2021-05-30
- First posted
- 2020-02-19
- Last updated
- 2022-11-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04276948. Inclusion in this directory is not an endorsement.